
Scientists Find Way to Grow New Lymph Vessels
Researchers have discovered that a natural molecule called IGF can trigger the growth of lymphatic vessels, offering the first real hope for treating lymphedema. For the 20% of breast cancer patients who develop painful, chronic swelling after surgery, this breakthrough could change everything.
A team at New Zealand's University of Auckland has identified a way to grow new lymphatic vessels, potentially ending decades of suffering for lymphedema patients who have had no cure available.
Lymphedema causes painful, persistent swelling when the lymphatic system gets damaged, usually after cancer treatment involving lymph node removal. The condition leads to fluid buildup, discomfort, and constant infection risk that patients manage for life.
Dr. Jonathan Astin and his team discovered that insulin-like growth factor (IGF), a molecule already well known in medicine, can stimulate lymphatic vessel growth. They first spotted this process in zebrafish, tiny transparent fish that scientists love because they can watch cells grow in real time without harming the animal.
The zebrafish results looked promising, but the real question was whether it would work in humans. The team partnered with colleagues to test IGF on human lymphatic cells grown in the lab, and the results confirmed it: IGF instructs human lymphatic vessels to grow too.

This discovery matters especially for breast cancer survivors. In New Zealand alone, one in five women who undergo lymph node removal during treatment develop lymphedema. Globally, millions live with this painful condition that has never had an effective treatment.
The Ripple Effect
This breakthrough extends beyond lymphedema patients. Understanding how to grow lymphatic vessels could help treat other conditions where the lymphatic system fails, from genetic disorders present at birth to injuries that damage these critical pathways. The research also highlights how studying simple organisms like zebrafish can unlock solutions for complex human diseases.
The team is now moving toward testing an IGF-based therapy in mice with lymphedema to confirm safety and effectiveness before human trials. While researchers remain cautiously optimistic, this represents the first viable path toward actually curing rather than just managing the condition.
For patients who have lived with daily pain and swelling, sometimes for decades, the possibility of regrowing their damaged lymphatic networks offers something they haven't had before: genuine hope for healing.
More Images




Based on reporting by Google News - Cure Discovery
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


